ANTIPLATELET THERAPY AFTER CORONARY ARTERY BYPASS GRAFT SURGERY – UNEVENNESS OF DAILY CLINICAL PRACTICE

Antiplatelet therapy is an integral part of optimal medicamentous therapy in patients with coronary artery disease. The strategy of antiplatelet/anticoagulant therapy is adjusted (combination of drugs, dosing and duration of therapy) depending on the stage of the disease (acute coronary syndrome wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Sopek-Merkaš, Ivana, Lakušić, Nenad, Fučkar, Krunoslav, Cerovec, Duško, Bešić, Kristina Marić
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sestre Milosrdnice University Hospital and Institute of Clinical Medical Research, Vinogradska cesta c. 29 Zagreb 2021
Materias:
Preliminary Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8907948/
https://www.ncbi.nlm.nih.gov/pubmed/35282474
http://dx.doi.org/10.20471/acc.2021.60.03.26

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8907948/
https://www.ncbi.nlm.nih.gov/pubmed/35282474
http://dx.doi.org/10.20471/acc.2021.60.03.26

Ejemplares similares